8 Results for "

CYP2A6-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "CYP2A6-IN-1" in MCE Product Catalog:

Cat. No.: HY-155456
Target:  

Cytochrome P450

Research Areas:  

Metabolic Disease

CD-6 is a flavonoid CYP2A6 inhibitor (IC50: 1.566 μM). CYP2A6 inhibits the metabolism of nicotine to cotinine, resulting in an increase in the amount of nicotine available in the blood, leading to increased smoking behavior. CD-6 mediates CYP2A6 inhibition and can be used in research on smoking cessation or smoking-related diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1184
CAS No.: 50-12-4
Target:  

Cytochrome P450

Research Areas:  

Neurological Disease

Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0043
CAS No.: 52705-93-8
Synonyms: Gypenoside VIII
Ginsenoside Rd inhibits TNFα-induced NF-κB transcriptional activity with an IC50 of 12.05±0.82 μM in HepG2 cells. Ginsenoside Rd inhibits expression of COX-2 and iNOS mRNA. Ginsenoside Rd also inhibits Ca 2+ influx. Ginsenoside Rd inhibits CYP2D6, CYP1A2, CYP3A4, and CYP2C9, with IC50s of 58.0±4.5 μM, 78.4±5.3 μM, 81.7±2.6 μM, and 85.1±9.1 μM, respectively.
loading...
    loading...
Cat. No.: HY-N8382
CAS No.: 13164-03-9
Chalepensin is a nematicide and CYP inhibitor. Chalepensin inhibits CYP2A6, CYP1A1, CYP1A2, CYP2A13, CYP2C9, CYP2D6, CYP2E1, and CYP3A4 to varying degrees, with IC50 values of 82.3 μM, 2.86 μM, 3.01 μM, 0.21 μM, 6.58 μM, 1.67 μM, 61.1 μM, and 61.7 μM, respectively. Chalepensin potently and selectively kills third-stage infective larvae of Strongyloides venezuelensis .
loading...
    loading...
Cat. No.: HY-B1184S1
CAS No.: 1185032-66-9
Mephenytoin-d5 is the deuterium labeled Mephenytoin. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate .
loading...
    loading...
Cat. No.: HY-B1184S
CAS No.: 1185101-86-3
(Rac)-Mephenytoin-d3 is a labelled racemic Mephenytoin. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate .
loading...
    loading...
Cat. No.: HY-B1184R
CAS No.: 50-12-4
Research Areas:  

Neurological Disease

Mephenytoin (Standard) is the analytical standard of Mephenytoin. This product is intended for research and analytical applications. Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate .
loading...
    loading...
Cat. No.: HY-N0043R
CAS No.: 52705-93-8
Synonyms: Gypenoside VIII (Standard)
Ginsenoside Rd (Standard) is the analytical standard of Ginsenoside Rd. This product is intended for research and analytical applications. Ginsenoside Rd inhibits TNFα-induced NF-κB transcriptional activity with an IC50 of 12.05±0.82 μM in HepG2 cells. Ginsenoside Rd inhibits expression of COX-2 and iNOS mRNA. Ginsenoside Rd also inhibits Ca2+ influx. Ginsenoside Rd inhibits CYP2D6, CYP1A2, CYP3A4, and CYP2C9, with IC50s of 58.0±4.5 μM, 78.4±5.3 μM, 81.7±2.6 μM, and 85.1±9.1 μM, respectively.
loading...
    loading...